← Leaderboards
David Ervin Lanar
University Of Connecticut Storrs
$1,073,429
Attributed
$2,146,858
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $578.3K · FY2009–12$1M$750K$500K$250K$0
'09
'10
'11
'12
Funding mix
By agency
NIH$2,146,858 · 1
By mechanism
R01$2,146,858 · 1
Top collaborators
- Peter Burkhard4 shared
Most similar at University Of Connecticut Storrs
Same institution · by research overlap
- Peter Burkhard$5,225,416
- Thanh Nguyen$8,155,049
Others in their field
Top investigators on “Adjuvanticity”
- Jay Evans · Corixa Corporation$13,735,700
- Nikolai Petrovsky · Vaxine Pty Ltd$10,786,491
- Luc Teyton · Scripps Research Institute, The$7,236,382
- Daniel A Portnoy · University Of California Berkeley$5,722,263
- Lee Mark Wetzler · Boston Medical Center$5,497,489
- Ofer Levy · Brigham And Women'S Hospital$5,439,291
Research focus
AdjuvanticityAntibody FormationAntigen PresentationAntigensAs02aBaseBiomedical EngineeringB-Lymphocyte EpitopesB-LymphocytesCd8b1 GeneCd8-Positive T-LymphocytesChildChimeric ProteinsCircumsporozoite ProteinClinical TrialsCoiled-Coil DomainCold ChainsCollaborationsConsultationsCrosslinkC-TerminalCulicidaeCytotoxicAdjuvant
Grant awards (4)
Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)$527,958
R01 · FY2012 · AI
Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)$543,351
R01 · FY2011 · AI
Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)$497,236
R01 · FY2010 · AI
Malaria Vaccine Based on Self-Assembling Polypeptide Nanoparticles (SAPN)$578,313
R01 · FY2009 · AI